Combined effects of antioxidant vitamin and NOS3 genetic polymorphisms on breast cancer risk in women

Clinical Nutrition

Volumn 31, Issue 1, 2012, Pages 93-98

  Lee, Sang Ah ^a   Lee, Kyoung Mu ^b   Yoo, Keun Young ^c   Noh, Dong Young ^c   Ahn, Sei Hyun ^d   Kang, Daehee ^c  

^a Kangwon National University   (South Korea)

^b Korea National Open University   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d University of Ulsan   (South Korea)

Author keywords

Antioxidant vitamin intake; Breast cancer risk; Gene diet interaction; NOS3 genetic polymorphisms

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; FOLIC ACID;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; NITRIC OXIDE SYNTHASE 3 GENE; NUTRITIONAL ASSESSMENT; NUTRITIONAL VALUE; ONCOGENE; RISK ASSESSMENT; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH KOREA; VITAMIN INTAKE;

ADULT; ANTIOXIDANTS; ASIAN CONTINENTAL ANCESTRY GROUP; BETA CAROTENE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, SINGLE NUCLEOTIDE; REPUBLIC OF KOREA; RISK FACTORS; VITAMIN E; VITAMINS;

EID: 84856234572     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2011.08.005     Document Type: Article

References (46)

1. Michels K.B., Mohllajee A.P., Roset-Bahmanyar E., Beehler G.P., Moysich K.B. Diet and breast cancer: a review of the prospective observational studies. Cancer 2007, 109(12 Suppl):2712-2749.
2. Nowell S.A., Ahn J., Ambrosone C.B. Gene-nutrient interactions in cancer etiology. Nutr Rev 2004, 62(11):427-438.
3. Li Y., Ambrosone C.B., McCullough M.J., Ahn J., Stevens V.L., Thun M.J., et al. Oxidative stress-related genotypes, fruit and vegetable consumption and breast cancer risk. Carcinogenesis 2009, 30(5):777-784.
4. Hong C.C., Ambrosone C.B., Ahn J., Choi J.Y., McCullough M.L., Stevens V.L., et al. Genetic variability in iron-related oxidative stress pathways (Nrf2, NQ01, NOS3, and HO-1), iron intake, and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2007, 16(9):1784-1794.
5. Ravn-Haren G., Olsen A., Tjonneland A., Dragsted L.O., Nexo B.A., Wallin H., et al. Associations between GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study. Carcinogenesis 2006, 27(4):820-825.
6. Cai Q., Shu X.O., Wen W., Cheng J.R., Dai Q., Gao Y.T., et al. Genetic polymorphism in the manganese superoxide dismutase gene, antioxidant intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Breast Cancer Res 2004, 6(6):R647-R655.
7. Zhen J., Lu H., Wang X.Q., Vaziri N.D., Zhou X.J. Upregulation of endothelial and inducible nitric oxide synthase expression by reactive oxygen species. Am J Hypertens 2008, 21(1):28-34.
8. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991, 43(2):109-142.
9. Fukumura D., Kashiwagi S., Jain R.K. The role of nitric oxide in tumour progression. Nat Rev Cancer 2006, 6(7):521-534.
10. Hussain S.P., Trivers G.E., Hofseth L.J., He P., Shaikh I., Mechanic L.E., et al. Nitric oxide, a mediator of inflammation, suppresses tumorigenesis. Cancer Res 2004, 64(19):6849-6853.
11. Ying L., Hofseth L.J. An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer. Cancer Res 2007, 67(4):1407-1410.
12. Drummond G.R., Cai H., Davis M.E., Ramasamy S., Harrison D.G. Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circ Res 2000, 86(3):347-354.
13. Loibl S., von Minckwitz G., Weber S., Sinn H.P., Schini-Kerth V.B., Lobysheva I., et al. Expression of endothelial and inducible nitric oxide synthase in benign and malignant lesions of the breast and measurement of nitric oxide using electron paramagnetic resonance spectroscopy. Cancer 2002, 95(6):1191-1198.
14. Vakkala M., Paakko P., Soini Y. eNOS expression is associated with the estrogen and progesterone receptor status in invasive breast carcinoma. Int J Oncol 2000, 17(4):667-671.
15. Martin J.H., Begum S., Alalami O., Harrison A., Scott K.W. Endothelial nitric oxide synthase: correlation with histologic grade, lymph node status and estrogen receptor expression in human breast cancer. Tumour Biol 2000, 21(2):90-97.
16. Wink D.A., Cook J.A., Pacelli R., DeGraff W., Gamson J., Liebmann J., et al. The effect of various nitric oxide-donor agents on hydrogen peroxide-mediated toxicity: a direct correlation between nitric oxide formation and protection. Arch Biochem Biophys 1996, 331(2):241-248.
17. Orucevic A., Bechberger J., Green A.M., Shapiro R.A., Billiar T.R., Lala P.K. Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasiveness. Int J Cancer 1999, 81(6):889-896.
18. Lancaster J.R., Xie K. Tumors face NO problems?. Cancer Res 2006, 66(13):6459-6462.
19. Nakayama M., Yasue H., Yoshimura M., Shimasaki Y., Kugiyama K., Ogawa H., et al. T-786-C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999, 99(22):2864-2870.
20. Meier J., Affeldt M., Opitz C., Kleber F.X., Speer A. Acommon base change in the promoter region of the human endothelial NO-synthase (NOS3) gene. Hum Mutat 1996, 8(4):394.
21. Lee K.M., Choi J.Y., Lee J.E., Noh D.Y., Ahn S.H., Han W., et al. Genetic polymorphisms of NOS3 are associated with the risk of invasive breast cancer with lymph node involvement. Breast Cancer Res Treat 2007, 106(3):433-438.
22. Choi J.Y., Lee K.M., Noh D.Y., Ahn S.H., Lee J.E., Han W., et al. Genetic polymorphisms of eNOS, hormone receptor status, and survival of breast cancer. Breast Cancer Res Treat 2006, 100(2):213-218.
23. Kim Y.I. Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer?. Cancer Epidemiol Biomarkers Prev 2004, 13(4):511-519.
24. Food composition table 2001, National Rural Living Science Institute Rural Development Administration, Suwon. 6th ed. I & II.
25. Stephens M., Donnelly P. Acomparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003, 73(5):1162-1169.
26. Page G.P., Amos C.I. Comparison of linkage-disequilibrium methods for localization of genes influencing quantitative traits in humans. Am J Hum Genet 1999, 64(4):1194-1205.
27. Hefler L.A., Ludwig E., Lampe D., Zeillinger R., Leodolter S., Gitsch G., et al. Polymorphisms of the endothelial nitric oxide synthase gene in ovarian cancer. Gynecol Oncol 2002, 86(2):134-137.
28. Medeiros R., Morais A., Vasconcelos A., Costa S., Pinto D., Oliveira J., et al. Endothelial nitric oxide synthase gene polymorphisms and genetic susceptibility to prostate cancer. Eur J Cancer Prev 2002, 11(4):343-350.
29. Ghilardi G., Biondi M.L., Cecchini F., DeMonti M., Guagnellini E., Scorza R. Vascular invasion in human breast cancer is correlated to T-786C polymorphism of NOS3 gene. Nitric Oxide 2003, 9(2):118-122.
30. Royo J.L., Moreno-Nogueira J.A., Galan J.J., Gonzalez-Martin A., Ruiz A., Gonzalez-Mancha R., et al. Lack of association between NOS3 Glu298Asp and breast cancer risk: a case-control study. Breast Cancer Res Treat 2006, 100(3):331-333.
31. Lu J., Wei Q., Bondy M.L., Yu T.K., Li D., Brewster A., et al. Promoter polymorphism (-786t>C) in the endothelial nitric oxide synthase gene is associated with risk of sporadic breast cancer in non-Hispanic white women age younger than 55 years. Cancer 2006, 107(9):2245-2253.
32. Hefler L.A., Grimm C., Lantzsch T., Lampe D., Koelbl H., Lebrecht A., et al. Polymorphisms of the endothelial nitric oxide synthase gene in breast cancer. Breast Cancer Res Treat 2006, 98(2):151-155.
33. Schneider B.P., Radovich M., Sledge G.W., Robarge J.D., Li L., Storniolo A.M., et al. Association of polymorphisms of angiogenesis genes with breast cancer. Breast Cancer Res Treat 2008, 111(1):157-163.
34. Yang J., Ambrosone C.B., Hong C.C., Ahn J., Rodriguez C., Thun M.J., et al. Relationships between polymorphisms in NOS3 and MPO genes, cigarette smoking and risk of post-menopausal breast cancer. Carcinogenesis 2007, 28(6):1247-1253.
35. Wang J., Dudley D., Wang X.L. Haplotype-specific effects on endothelial NO synthase promoter efficiency: modifiable by cigarette smoking. Arterioscler Thromb Vasc Biol 2002, 22(5):e1-e4.
36. Gandini S., Merzenich H., Robertson C., Boyle P. Meta-analysis of studies on breast cancer risk and diet: the role of fruit and vegetable consumption and the intake of associated micronutrients. Eur J Cancer 2000, 36(5):636-646.
37. Key T. Micronutrients and cancer aetiology: the epidemiological evidence. Proc Nutr Soc 1994, 53(3):605-614.
38. Bingham S. The fibre-folate debate in colo-rectal cancer. Proc Nutr Soc 2006, 65(1):19-23.
39. Kabat G.C., Miller A.B., Jain M., Rohan T.E. Dietary intake of selected B vitamins in relation to risk of major cancers in women. Br J Cancer 2008, 99(5):816-821.
40. Ambs S., Hussain S.P., Harris C.C. Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J 1997, 11(6):443-448.
41. Wink D.A., Kasprzak K.S., Maragos C.M., Elespuru R.K., Misra M., Dunams T.M., et al. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991, 254(5034):1001-1003.
42. Shen Y.H., Wang X.L., Wilcken D.E. Nitric oxide induces and inhibits apoptosis through different pathways. FEBS Lett 1998, 433(1-2):125-131.
43. Jadeski L.C., Hum K.O., Chakraborty C., Lala P.K. Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis. Int J Cancer 2000, 86(1):30-39.
44. Tse G.M., Wong F.C., Tsang A.K., Lee C.S., Lui P.C., Lo A.W., et al. Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumour. JClin Pathol 2005, 58(6):600-604.
45. Nakamura Y., Yasuoka H., Tsujimoto M., Yoshidome K., Nakahara M., Nakao K., et al. Nitric oxide in breast cancer: induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis. Clin Cancer Res 2006, 12(4):1201-1207.
46. Ock S.M., Hwang S.S., Lee J.S., Song C.H., Ock C.M. Dietary supplement use by South Korean adults: data from the national complementary and alternative medicine use survey (NCAMUS) in 2006. Nutr Res Pract 2010, 4(1):69-74.